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Abstract
Background: The outcome of preterm infants has been varied in different hospitals and regions in developing
countries. Regular clinical monitor are needed to know the effects of health care. This study aimed to describe the
survival and morbidity rates of extreme to very preterm infants in 15 neonatal-intensive care hospitals in China.
Methods: Data were collected from January 1, 2013 to December 31, 2014 for preterm neonates with gestational age
(GA) between 24 and 31 complete weeks born in hospitals from our collaborative study group. The primary outcomes
were survival and major morbidities prior to hospital discharge. Major morbidities included bronchopulmonary dysplasia
(BPD), intraventricular hemorrhage (IVH), necrotizing enterocolitis (NEC), retinopathy of prematurity (ROP), patent ductus
arteriosus (PDA) and sepsis. Mutivariate logistic regression was used to analyze the risk factor influencing on the outcomes.
Results: The preterm birth rate was 9.9 % (13 701/138 240). The proportion of extreme to very preterm infants was 1.
1 % and 11.8 % respectively. The survival rate prior to discharge was increased with increasing GA (0, 24 weeks; 28 %,
25 weeks; 84.8 %, 26 weeks; 83.5 %, 27 weeks; 87.4 %, 28 weeks; 90.7 %, 29 weeks; 93.9 %, 30 weeks; 96 %, 31 weeks).
Rate of survival and without severe morbidity according to GA were 0 at 24 weeks, 8 % at 25 weeks, 60.6 % at
26 weeks; 53.2 % at 27 weeks; 62.3 % at 28 weeks; 67.9 % at 29 weeks; 79.1 % at 30 weeks, 85.8 % at 31 weeks
respectively. Rate of antenatal steroid use was 56 %. The antenatal steroid use was lower in GA < 28 weeks infants than
that in GA between 28 and 32 weeks (28–44.3 % vs 49.7–60.1 %, P < 0.05). Infants at the lowest GAs had a highest
incidence of morbidities. Overall, 58.5 % had respiratory distress syndrome, 12.5 % bronchopulmonary dysplasia, 3.9 %
necrotizing enterocolitis, 15.4 % intraventricular hemorrhage, 5.4 % retinopathy of prematurity, 28.4 % patent ductus
arteriosus, and 9.7 % sepsis. Mortality and morbidity were influenced by gestational age (OR = 0.891, 95 % CI: 0.796–0.
999, p = 0.0047 and OR = 0.666, 95 % CI: 0.645–0.688, p = 0.000 respectively), birth weight (OR = 0.520, 95 % CI: 0.420–0.
643, p = 0.000 and OR = 0.921, 95 % CI: 0.851–0.997, p = 0.041 respectively), SGA (OR = 1.861, 95 % CI: 1.148–3.017, p = 0.
012 and OR = 1.511, 95 % CI: 1.300–1.755, p = 0.000 respectively), Apgar score <7 at 5 min (OR = 1.947, 95 % CI: 1.269–2.
987, p = 0.002 and OR = 2.262, 95 % CI: 1.950–2.624, p = 0.000 respectively). The survival rate was increased with more
prenatal steroid use (OR = 1.615, 95 % CI: 1.233–1.901, p = 0.033).
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Conclusion: Although most of the preterm infants with GAs ≥26 weeks survived, a high complication in survivors still
can be observed. Rate of survival of GAs less than 26 weeks was still low, and quality improvement methods should be
used to look into increasing the use of antenatal steroids in the very preterm births.
Keywords: Preterm infants, Mortality, Morbidity, Outcome
Background
In 2010, the national preterm birth rate was estimated at
14.9 million infants or more than one in ten of all
infants in 184 countries [1]. More than a million of those
infants died mainly because of severe complications
associated with premature birth. Prematurity was the
leading cause of death in the first month of life and was
a factor in greater than 75 % of early deaths in the
neonatal period [1]. Across all regions, although infants
born at less than 32 weeks account for about 16 % of all
preterm births, mortality and morbidity were the highest
among these infants [2]. Even though there have been
ongoing advances in neonatal intensive care and a sig-
nificant decline in neonatal mortality in the past several
decades, there is still much room for improvement in
morbidity and mortality among very preterm infants
(VPI: gestational age <32 weeks) and extremely preterm
infants (EPI: gestational age <28 weeks) [3–5]. In order
to make the best solution for the prevention of morbid-
ity and mortality in VPI and EPI, it is essential to
continue monitoring the outcomes among these
high-risk infants.
Although China is one of the most populous countries
in the world, the outcomes of newborn infants and the
associated risk factors are only estimated by vital statis-
tics. It may address public health concerns with regards
to overall mortality and related causes, but does not
answer questions pertaining to specific perinatal and
neonatal care, gestation specific mortalities and morbid-
ities, risk factors, as well as resuscitation and postnatal
care of these high risk newborns [6]. In China, only a
few publications analyzed the short-term outcome of
preterm infants on a nationwide basis over more than
ten years. We previously published a single-center age-
specific outcome study of preterm infants less than
32 weeks gestation born between 2010 and 2012 [7].
However, more recently, several national neonatal net-
works have established and compared their data to
assess the differences in outcomes, and to identify the
progress in the whole areas. On this ground, the aim of
our current study is to evaluate the hospital outcomes of
the live born preterm infants less than 32 weeks gesta-
tion at birth admitted to any of the 15 hospitals in China
from 2013 to 2014. And to format gestational age-
specific hospital survival rates and major morbidity rates
taking into account common perinatal risk factors that
were known to affect the outcomes of preterm infants.
We also compared the current outcomes for VPI with
outcomes from other countries.
Methods
Participating centers
We established a collaborative study group including
nine general hospitals and six maternal and children’s
hospitals from major cities of 11 provinces in China. All
the participating hospitals are tertiary neonatal care cen-
ters and have their own maternity wards in local region,
which are representatives of medical units providing
newborn intensive care in their respective areas. Nine
neonatal intensive care units (NICU) of all the partici-
pating hospitals provide regional perinatal and neonatal
retrieval services. In this prospective study design, our
study was approved by the Institutional Ethics
Committee of the Army General Hospital, the People’s
Liberation Army (PLA). The approval of data collection
was also obtained at each of the collaborating hospitals.
This study was also conducted as part of the Neonatal
Research Network of the Chinese Neonatologist
sub-association of the Chinese Medical Doctor
Association. Coordination for this study was based at
the Army General Hospital of PLA.
Study population and clinical outcomes
Infants born alive at hospitals of our collaborative study
group in 2013–2014 with GAs of 24+0 to 31+6 weeks
were studied, excluding those with congenital anomalies.
Outborn infants were also excluded in this investigation.
Researchers collected maternal pregnancy/delivery data
soon after birth and infant data from birth to death or
discharge. To minimize bias among centers and investi-
gators, we provided comprehensive and systematic train-
ing for the staffs committed to the survey. Data
collection by research staff at each of the collaborating
hospitals was supervised by the NICU director, who was
responsible for the quality assurance. The quality control
was mainly focused on completeness and accuracy of
the contents in records by each unit investigators, along
with visiting, telephone or email communication for
verification and correction of the data. Records were also
subjected to collaborative center to check for accuracy
and completeness and returned for correction if needed.
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GA was determined by the most experienced obstetric
physicians estimated by the date of last menstrual
period. Preterm infants was defined as a GA <37 com-
pleted weeks. Extremely preterm infant (EPI) was
defined as GA < 28 weeks and very preterm infants
(VPI) was defined as GA < 32 weeks. Small for gesta-
tional age (SGA) infant was defined as birth weight of
<10th percentile for gender and GA, by using growth
charts published by Fenton and Kim [8]. Birth weight
was recorded within 1 h of birth. Antenatal care was
defined as receiving an obstetrician at least one occasion
during pregnancy.
Morbidities were defined according to the earlier pub-
lications [3, 9–11], including: (1) respiratory distress
syndrome (RDS): (i)clinical evidence of respiratory diffi-
culties (tachypnea, retraction, grunting and cyanosis),
(ii)radiographic appearance of RDS (low volume lungs
with a diffuse reticulogranular pattern and air broncho-
grams). (2) bronchopulmonary dysplasia (BPD): Infants
were considered as having BPD if they required mechan-
ical ventilation or supplemental oxygen 28 days after
birth. Moderate to severe BPD were defined as infants
who still received supplemental oxygen at 36 weeks’
postmenstrual age (PMA) or at discharge. (3) intraven-
tricular hemorrhage (IVH): IVH was diagnosed within
28 days of birth by using real-time portable cranial ultra-
sound. Severe IVH was defined as Grades III and IV
according to the Papile grading system based on head
ultrasound. (4) necrotizing enterocolitis (NEC): The
diagnosis of NEC required ≥1abdominal sign (eg, bilious
gastric aspirate or vomitting, abdominal distention or
tenderness, gross or occult blood in the stool) and ≥1
radiographic finding (eg, pneumatosis intestinalis, hepa-
tobiliary gas, a fixed position loop on serial studies).
High grade NEC was ≥ grade II according to modified
Bell’s criteria. (5) retinopathy of prematurity (ROP): The
diagnosis and staging of ROP were based on retinal
examination before discharge with severe ROP defined
as stages 3 to 5. (6) Sepsis, including positive blood
culture and clinical diagnosis.
Mortality was defined as death in the delivery room or
in NICU before discharge. Infants were considered as
having a major neonatal morbidity if they had at least
one of the following complications before discharge:
moderate to severe BPD, severe IVH, high grade NEC,
severe ROP and sepsis. Combined outcome refers to
infants who died or survived with a major neonatal
morbidity. Infants who died in delivery room were
excluded from analyses focus on morbidity diagnosed
later after birth.
Statistical analysis
All statistical analyses were conducted by using SPSS
16.0 software (SPSS, Chicago, IL). Continuous variables
are described as means and SD. Categorical variables are
presented as rates and odds ratio with 95 % confidence
intervals (CI). Comparison between continuous variables
was conducted by using a One-way ANOVA. Univariate
analyses on categorical variables were made by using a
2-tailed Pearson χ2 or Fisher’s exact test wherever
appropriate.
Multivariate analyses were performed separately by
using logistic regression to analyze the risk factors of
mortality and morbidity in preterm infants. GA, gender,
maternal perinatal complications such as: Gestational
diabetes, Placenta previa, placental abruption, hyperten-
sive disorder complicating pregnancy (HDCP) and
Premature rupture of membrane (PROM), multiple
birth, delivery mode, Small for GA, Apgar score and ante-
natal steroid use were included in the analysis. P < 0.05
was considered statistically significant.
Results
Incidence of preterm birth
During a two-year period, there were 138 240 alive born
infants including 13 701 preterm infants from the 15
participating hospitals. The incidence of preterm birth
rate was 9.9 %. Of these, there were totally 1 760 infants
born before 32 weeks (including 148 and 1 612 EPI and
VPI, corresponding to 1.1 % and 11.8 % of all preterm
infants respectively). The number of preterm infants in-
creased with increasing GA. See Table 1.
Characteristics of study infant
Overall, there were 1 001(56.9 %) male infants,
514(29.2 %) multiple births, and 116(6.6 %) small for ges-
tational age infants. Infants with Apgar scores of <7 at
5 min represented 9.0 % of all EPI and VPI, and the inci-
dence was high in lower GA infants. Caesarean sections
were done in 710 (40.3 %) infants and the rate was
increased with increased GA, with 9.1 % at 24 weeks and
50.3 % at 31 weeks (OR 1.168; 95 % confidence interval
(CI) 1.149–1.187; p = 0.000). The majority (89.7 %) of
women received antenatal care. Rate of antenatal steroid
use increased with advancing GA, from 0 at 24 weeks to
44.3 % at 27 weeks and 49.7 % to 59.6 % at 28 to 31 weeks.
The rate of complete antenatal steroid use was 32.3 % and
also increased with GA. (see Table 1).
Hospital survival rate
54/1 760 (3.1 %) live born infants died during the first
week after birth, ranging from 54.5 % at 24 weeks, 3.5 %
at 28 weeks to 0.3 % at 31 weeks of gestation. In 22.2 %
of the early deaths, a discontinued treatment policy was
made according to parents’ opinion before birth: 45.5 %
at 24 weeks of gestation, 15.2 % at 25 weeks, 3.0 % at
26 weeks of gestation. In total, there was no infant
survived at 24 weeks gestation. Rates of survival before
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discharge increased with the increase of GA, from 28 %
at 25 weeks, 84.8 % at 26 weeks, 83.5 % at 27 weeks,
87.4 % at 28 weeks, 90.7 % at 29 weeks, 93.9 % at
30 weeks and to 96.0 % at 28 weeks (91.2 % overall).
There was a large increase in survival of greater than
50 % from 25 week to 26 gestational weeks. The survival
rate was over 90 % in 29 weeks, 30 weeks and 31 weeks
of gestation. (Table 2).
Mutivariate logistic regression analysis indicated that
the mortality of GA < 32 weeks preterm infants was de-
creased with increasing gestational age (OR = 0.891, 95 %
CI: 0.796–0.999, p = 0.0047), birth weight (OR = 0.520, 95
% CI: 0.420–0.643, p = 0.000), and more antenatal steroids
use (OR = 1.615, 95 % CI: 1.233–1.901, p = 0.033). Infants
with SGA and Apgar < 7 at 5 min died more often than
infants with infants who have no these risk factors (OR =
1.861, 95 % CI: 1.148–3.017, p = 0.012; OR = 1.947, 95 %
CI: 1.269–2.987, p = 0.002, respectively). (Table 3).
Major neonatal morbidity
The smaller of the GA, there was a greater risk of mor-
bidities due to prematurity (Table 2). Overall, 58.5 % in-
fants experienced RDS. The incidence of RDS was over
85 % among infants at 24–27 weeks. The risk of BPD
was inversely proportional to the GA at birth. Because
of the inclusion of infants with mild BPD, the incidence
Table 2 Survive and morbidity rate according to GA for infants <32 weeks from 2013 to 2014
Gestational age 24 weeks 25 weeks 26 weeks 27 weeks 28 weeks 29 weeks 30 week 31 week Total
Numbers (%) 11 25 33 79 199 321 444 648 1760
Died within 7 days (%) 6 (54.5) 13 (52.0) 3 (9.1) 8 (10.1) 7 (3.5) 9 (2.8) 6 (1.4) 2 (0.3) 54 (3.1)
Died before discharge (%) 5 (45.5) 5 (20.0) 2 (6.1) 5 (6.3) 18 (9.1) 21 (6.5) 21 (4.7) 24 (3.7) 101 (5.7)
Survived to discharge (%)a 0 (0) 7 (28.0) 28 (84.8) 66 (83.5) 174 (87.4) 291 (90.7) 417 (93.9) 622 (96.0) 1605 (91.2)
Survived without morbidity (%)b 0 (0) 2 (8.0) 20 (60.6) 42 (53.2) 124 (62.3) 218 (67.9) 351 (79.1) 556 (85.8) 1313 (74.6)
Died or survived with at least
one morbidity (%)
11 (100) 23 (92.0) 13 (39.4) 37 (46.8) 75 (37.7) 103 (32.1) 93 (20.9) 92 (14.2) 447 (25.4)
RDS (%) 10 (90.9) 22 (88.0) 29 (87.9) 69 (87.3) 167 (83.9) 223 (69.5) 234 (52.7) 276 (42.6) 1030 (58.5)
BPD (%)c - 4 (57.1) 11 (39.3) 20 (30.3) 45 (25.9) 63 (21.6) 33 (7.9) 24 (3.9) 200 (12.5)
NEC (%)d - 0 (0) 2 (6.7) 7 (9.9) 13 (6.8) 11 (3.5) 10 (2.3) 23 (3.6) 66 (3.9)
IVH (%)d - 5 (41.7) 7 (23.3) 23 (32.4) 31 (16.1) 50 (16.0) 61 (13.9) 85 (13.2) 262 (15.4)
PDA (%)d - 4 (33.3) 11 (36.7) 30 (42.3) 59 (30.7) 102 (32.7) 117 (26.7) 162 (25.1) 485 (28.4)
ROP (%)c - 2 (28.6) 5 (17.9) 10 (15.2) 18 (10.3) 21 (7.2) 16 (3.8) 14 (2.3) 86 (5.4)
Sepsis (%)a - 5 (20.0) 7 (21.2) 11 (13.9) 33 (16.6) 35 (10.9) 42 (9.5) 37 (5.7) 170 (9.7)
RDS respiratory distress syndrome, BPD bronchopulmonary dysplasia, including mild, moderate and severe BPD, NEC necrotizing enterocolitis, including stage I, II
and III, IVH intraventricular hemorrhage, including grade I, II, III and IV, ROP retinopathy of prematurity; including stage I, II, III, IV and V. PDA Patent
ductus arteriosus
a Proportion among all infants including survivors
bMorbidity including moderate to severe BPD, severe IVH, high grade NEC, sepsis and ROP stage ≥3
cProportion among infants who survived
dProportion among infants who survived > 7 days
Table 1 Neonatal characteristics of the study infants by gestational age
Gestational age 24 weeks 25 weeks 26 weeks 27 weeks 28 weeks 29 weeks 30 weeks 31 weeks Total
Numbers (%) 11 (0.6) 25 (1.4) 33 (1.9) 79 (4.5) 199 (11.3) 321 (18.2) 444 (25.2) 648 (36.8) 1760 (100)
Males (%) 4 (36.4) 15 (60.0) 22 (66.7) 47 (59.5) 122 (61.3) 173 (53.9) 267 (60.1) 351 (54.2) 1001 (56.9)


















Multiple birth (%) 3 (27.3) 12 (48.0) 7 (21.2) 34 (43.0) 56 (28.1) 76 (23.7) 124 (27.9) 202 (31.2) 514 (29.2)
Caesarean section (%) 1 (9.1) 3 (12.0) 6 (18.2) 14 (17.7) 64 (30.7) 111 (34.6) 185 (41.7) 326 (50.3) 710 (40.3)
SGA (%) 0 (0) 4 (16.0) 1 (3.0) 2 (2.5) 10 (5.0) 18 (5.6) 37 (8.3) 44 (6.8) 116 (6.6)
5 min Apgar score <7 (%) 7 (63.6) 5 (20.0) 12 (36.4) 20 (25.3) 33 (16.6) 25 (7.8) 36 (8.1) 21 (3.2) 159 (9.0)
Antenatal care (%) 9 (81.8) 20 (80.0 %) 29 (87.9) 70 (88.6) 174 (87.4) 286 (89.1) 401 (90.3) 589 (90.9) 1578 (89.7)
Antenatal steroid use (%) 0 (0) 7 (28.0) 11 (33.3) 35 (44.3) 99 (49.7) 186 (57.9) 262 (59.0) 386 (59.6) 986 (56.0)
Complete antenatal steroid
use (%)
0 (0) 3 (12.0) 5 (15.2) 17 (21.5) 48 (24.1) 115 (35.8) 159 (35.8) 221 (34.1) 568 (32.3)
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of BPD was 12.5 % in total with the severity-based defin-
ition of BPD. Overall, 15.4 % of cranial sonograms indi-
cated IVH decreased with the increase of GA (41.7 % at
25 weeks and 13.2 % at 31 weeks). A highest incidence of
sepsis was diagnosed at the lowest GA (20 % at 25 weeks
and 5.7 % at 31 weeks). 3.9 % of infants developed NEC.
PDA was diagnosed for 28.4 % of infants who survived
>7 days. The average incidence of ROP was 5.4 % and the
interval was from 28.6 % at 25 weeks to 2.3 % at 31 weeks.
Rates of died or survived with at least one morbidity
decreased with the increase of GA (100 % at 24 weeks to
92 % at 25 weeks, 39.4 % at 26 weeks, 46.8 % at 27 weeks,
37.7 % at 28 weeks, 32.1 % at 29 weeks, 20.9 % at 30 weeks,
and 14.2 % at 31 weeks).
Mutivariate logistic regression analysis indicated that
the morbidity of GA < 32 weeks preterm infants was
decreased with increasing gestational age (OR = 0.666,
95 % CI: 0.645–0.688, p = 0.000) and birth weight (OR =
0.921, 95 % CI: 0.851–0.997, p = 0.041). SGA(OR = 1.511,
95 % CI: 1.300–1.755, p = 0.000), HDCP(OR = 1.209, 95
% CI: 1.054–1.387, p = 0.007), placental abruption(OR =
1.380, 95 % CI: 1.082–1.760, p = 0.010), placenta
previa(OR = 1.452, 95 % CI: 1.202–1.753, p = 0.000), mul-
tiple birth(OR = 1.162, 95 % CI: 1.056–1.278, p = 0.002),
Apgar < 7 at 5 min(OR = 2.262, 95 % CI: 1.950–2.624, p =
0.000) and maternal fever before delivery(OR = 1.367, 95 %
CI: 1.228–1.521, p = 0.000) were associated with increased
risk of morbidity.
Discussion
The incidence of preterm birth and mortality is associ-
ated with the level of economic development, quality of
medical technology and advance in perinatal care.
Although preterm birth has decreased in some high-
income countries, the worldwide rates have increased
during the last decade [1, 2]. In 2010, the number of
premature birth was about 14.9 million, account for
11.1 % of all live births worldwide, ranging from about
5 % in several European countries to 18 % in some
African countries. In China, The rate of preterm infant
had steadily increased from the early 2000s. In 2002–
2003, the incidence of preterm infants was 7.8 %
accounting for 19.7 % in hospitalization neonates [12].
The number was increased to 8.1 % in 2005 and to
8.81 % during 2010–2011 according to regional reports
[13, 14]. In our data, rate of preterm birth was 9.9 %.
Premature birth rate in China is now comparable to
other developed countries and this is likely to increase
over the years due to increase in maternal age and use
of assisted conception, and also because many of the EPI
and VPI might be reported stillbirth before. Improve-
ment in maternal and newborn infant health care would
have an impact on survival of the more premature
infants. Although babies born at GA < 32 weeks
accounted for 12.9 % of preterm births, they however
accounted for >50 % of infant death and neurodevelop-
mental disabilities [3, 13, 14].
Although many previous reports used birth weight
(BW) as the reference for morbidity and mortality, the
current study assessed outcomes in accordance with GA.
BW specific data may not be accurate because of the
limited growth of more mature infants. Appreciation of
GA-based outcomes is especially valuable for prenatal
counseling and physician/family decision-making [11].
Table 3 Multivariate logistic regression analysis of risk factors for mortality and severe morbidity
Factors Mortality Morbidity
B value Wald OR 95 % CI P B value Wald OR 95 % CI P
GA −0.115 3.930 0.891 0.796–0.999 0.047 −0.406 624.097 0.666 0.645–0.688 0.000
Birth weight −0.654 36.228 0.520 0.420–0.643 0.000 −0.082 4.160 0.921 0.851–0.997 0.041
male 0.165 1.655 1.180 0.917–1.518 0.198 0.211 22.444 1.235 1.132–1.347 0.000
Caesarean section 0.278 2.364 1.321 0.926–1.884 0.124 0.027 0.505 1.027 0.954–1.105 0.477
Antenatal steroid use 0.191 1.943 1.615 1.233–1.901 0.033 0.021 0.199 1.021 0.933–1.117 0.655
Gestational diabetes −0.273 0.579 0.761 0.377–1.537 0.447 −0.099 1.521 0.906 0.775–1.060 0.218
SGA 0.621 6.349 1.861 1.148–3.017 0.012 0.413 29.072 1.511 1.300–1.755 0.000
PROM −0.161 0.847 0.851 0.604–1.200 0.357 0.027 0.481 1.027 0.953–1.107 0.488
placental abruption 0.511 3.328 1.667 0.963–2.887 0.068 0.322 6.711 1.380 1.082–1.760 0.010
Placenta previa −0.202 0.424 0.817 0.444–1.502 0.515 0.373 15.037 1.452 1.202–1.753 0.000
HDCP 0.141 0.421 1.151 0.753–1.760 0.517 0.190 7.358 1.209 1.054–1.387 0.007
Multiple birth −0.017 0.009 0.983 0.698–1.384 0.923 0.150 9.502 1.162 1.056–1.278 0.002
Apgar < 7 at 5 min 0.666 9.321 1.947 1.269–2.987 0.002 0.816 116.087 2.262 1.950–2.624 0.000
Maternal fever before delivery 0.100 0.292 1.105 0.770–1.585 0.589 0.312 32.891 1.367 1.228–1.521 0.000
GA gestational age, SGA small for gestational age, PROM Premature rupture of membrane, HDCP hypertensive disorder complicating pregnancy
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GA was determined mainly based on the first day of last
menstrual period and not on early ultrasonic scan in this
study because the accuracy of estimate by ultrasonog-
raphy is decreased with increasing GA. The variation is
up to 2 weeks at 28 weeks, and this may have an impact
on the results of this study.
This study on outcome of 24 to 31 weeks premature
infants in China showed a survival rate of 91.2 % (mor-
tality rate was 8.8 %) among live born infants. 74.6 % of
infants had discharged home without any severe morbid-
ity during their hospital stay. The survival rate was
slightly increased than that of reported in previous data
in China, although the survival rate of EPI and VPI vary
greatly. A study from Jiangsu province in China in 2010
had reported the survival rate of 25 weeks to 31 weeks
was 0, 0, 58.3 %、66.7 %、60.3 %、82.9 % and 79.2 %
respectively6. In Guangdong province of China, the sur-
vival rate of EPI was 20 % at 24 weeks、15.9 % at
25 week、27.2 % at 26 week and 48.4 % at 27 weeks. Ac-
cording to birth weight the survival rate of ELBW in-
fants were also vary from 38.5 to 87 % in China [15]. In
Canada, the Canada neonatal network (CNN) data
showed significantly decrease in mortality rate of GA
<29 weeks from 1996 to 1997 (17.2 %) to 2006–2007
(14.7 %) [16]. Isayama et al. had compared Neonatal Re-
search Network of Japan (NRNJ) data with CNN data in
2006–2008, the mortality rate at GA < 25 weeks, 26–27
weeks, 28–29 weeks and 30–32 weeks were 27.1 % vs
52.3 %、9.6 % vs 17.9 %、4.1 % vs 7.3 % and 1.4 % vs
1.7 %. It indicated that the mortality rate was higher in
Canada than that in Japan, especially in lowest GA [17].
New South Wales and the Australian Capital Territory
Neonatal Intensive Care Units’ Data showed the survival
rate of GA between 22 and 31 weeks was
26.8 %、59.1 %、75.6 %、85.1 %、91.1 %、95.6 %、97.2-
%、97.8 % and 98.6 %. It indicated their survival rate
was more than 95 % between 28 and 31 weeks [11]. Our
data showed there was no survivor of infants for
24 weeks of GA and high rate in early death. Infants
born at 25 weeks had more than three times the risk of
death, compared with infants born at 26 weeks. The sur-
vival rate at 26 to 27 weeks and 28 to 31 weeks were
steadily closed to developed countries. Furthermore,
there is still controversy about whether to provide active
obstetric care and to initiate neonatal intensive care to
the EPI in China. There are no authoritative policies or
guidelines for physicians to abide whether a 24 weeks in-
fant should give intensive resuscitation or not. Mostly it
was up to the parents’ opinion. It was common that
some EPIs were stopped intensive care in the shortly
after birth, in the early or late process of treatment due
to shortage of money and poor prognosis. It means some
of the infant may survive if treatment were to continue.
On this ground, the estimate of survival rate will be
slightly low. So there were unavoidable errors in some
degree about the survival rate of these infants.
The incidence of hospital morbidity rate was still high
among EPIs, and morbidities contribute to poor neuro-
developmental outcomes. Our data showed the
combined outcome of death or ≥1 major neonatal mor-
bidity in survivors was 100 % at 24 weeks and 92 % at
25 weeks, decreased to 39.4 % among 26 weeks and
14.2 % at 31 weeks. This is a big gap compared to data
from other countries [18, 19]. In Japan, the NRNJ data
showed the combined outcome of death and/or neuro-
development impairment in survivors in 22 to 25 weeks
was 80 %、63.7 %、38.9 % and 34.1 % respectively [18].
In the United States, the National Institute of Child
Health and Human Development (NICHD) Neonatal
Research Network showed that the composite outcome
in 22 to 28 weeks was 100 % 22 weeks; 86 %–91 %,
23 weeks; 95 %–89 %, 24 weeks; 80 %–78 %, 25 weeks;
68 %–66 %, 26 weeks; 56 %–54 %, 27 weeks and 46 %–
38 %, 28 weeks [19]. Most infants experienced a major
complication during the first hospitalization, with the
risk of morbidity being inversely related to GA at birth.
Many studies showed the major neonatal morbidities
are predictive of long-term neurodevelopmental disor-
ders such as cerebral palsy, cognitive impairment,
hearing loss, and visual problem [16–22]. We can assess
the risks for long-term neurodevelopmental disorders by
using the results of Schmidt et al. [22], who reported
that three neonatal morbidities including BPD, severe
brain injury (grade III or IV IVH, PVL and porencepha-
lic cysts), and severe ROP, strongly predict poor neuro-
developmental outcome (motor impairment, cognitive
disorders, behavior problems, poor general health,
hearing loss, and visual problem) at 5 years for very low
birth infants. The incidence of BPD, serious brain injury,
and severe ROP were account for 43 %, 13 %, and 6 % in
all infants, respectively. Each of the three morbidities
was similarly and independently correlated with adverse
5-year outcome. The incidence of death or disability
(95 % CI) in infants with none, any one, any two, and all
three morbidities was 11.2 % (9.0 %–13.7 %), 22.9 %
(19.6 %–26.5 %), 43.9 % (35.5 %–52.6 %), and 61.5 %
(40.6 %–79.8 %), respectively. Among EPIs born at
United State academic centers, modest reductions in
several morbidities were observed, but BPD was
increased over the last 20 years [23]. So how to reduce
the high rates of in-hospital morbidity among EPIs who
are provided ongoing intensive care remains a challenge
for our neonatologists.
Multiple factors were associated with neonatal mortal-
ity and morbidity. In current study, it was identified that
perinatal factors including antenatal steroids, gender,
SGA, low Apgar score at 5 min, HDCP, placental abrup-
tion, placenta previa and multiple birth have an impact
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on the survival rate or morbidity rate. Previous study
showed antenatal steroids use can improve the perinatal
health in preterm infants [24, 25]. Our data showed the
proportion of antenatal steroids was very low compared
with other country [3, 11]. A possible explanation for
the low incidence of antenatal steroids use in current
study is the Chinese policy about “one child in one fam-
ily” and futile medical care; the pregnancy will be termi-
nated when the infants long-term outcomes are not as
good as expected, especially in GA < 26 weeks [13–15].
ACOG Committee on Obstetric Practice recommended
that a single course of corticosteroids should be admin-
istrated for pregnant women from 24 weeks to 34 weeks
of GA who are at risk of preterm delivery within 7 days
[26]. The 2013 European consensus guidelines for RDS
have given the same recommendation on antenatal
steroids use [27]. But in China, the present guideline
from Obstetrics and Gynecology Society of Chinese
Medical Association only suggested to give corticoste-
roids for pregnant women between 28 and 34 weeks of
gestation, not including less than 28 weeks pregnant
women [28]. Following the improving in neonatal
intensive care, more and more EPIs were survived in
China. So it is essential for our clinicians to start give
active treatment strategy from 24 weeks.
The strengths of this study are the prospective,
GA-based and a multicenter survey. The design of the
study makes it was comparable to other GA-based co-
hort studies of extremely and very premature infants
and provides information on the international position.
Adopting methods from other countries in China might
improve outcomes by analyzing multicenter data period-
ically for benchmarking, and assessing quality improve-
ment initiatives. Our results may be valuable in
counseling families and making novel interventions in
China. We acknowledge inevitably there are several limi-
tations. We only presented short-term outcomes in this
study. The long-term neurodevelopmental outcome
analysis is needed for this cohort study. The other disad-
vantage of this dataset is that the analysis is restricted to
the information collected. We did not present any other
data that might influence the outcomes of preterm
infants such as maternal age, socio-economic status and
details in clinical management strategy. Finally, this
study was limited to liveborn preterm neonates of 24 to
31 complete weeks admitted to NICU, and we did not
take into account any stillbirths and more immature
babies less than 24 weeks. It hard to distinct if the cause
of stillbirth at 24–25 weeks gestation was not influencing
by the decisions of parents.
Conclusion
In summary, we presented the hospital outcomes of
extreme to very preterm infants from well-selective
regional hospitals in China. Our study highlighted that
many perinatal factors were associated with the mortal-
ity and morbidity besides gestational age and birth
weight. Infants born at 24 and 25 weeks’ gestation were
at higher risk of death than infants born at more than
26 weeks’ gestation. There is a need for further discus-
sions on management for infants born at 24 and
25 weeks’ gestation.
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